Showing results (1101-1110 of 1,272) with videos related to
Sort By:
Pageof 128
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.Nature|February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeSevin Turcan, Daniel Rohle, Anuj Goenka, et al.Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.Ebiomedicine|September 19, 2016
Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are PredictiveStefan Taudien, Ludwig Lausser, Evangelos J Giamarellos-Bourboulis, et al.Nature Cell Biology|September 20, 2024
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognitionArseniy E Yuzhalin, Frank J Lowery, Yohei Saito, et al.Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.Plos One|October 24, 2008
Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activityThore Santel, Gabi Pflug, Nasr Y A Hemdan, et al.CNS Oncology|May 16, 2022
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant gliomaJohn de Groot, Martina Ott, Jun Wei, et al.Science Immunology|June 28, 2024
Single-cell topographical profiling of the immune synapse reveals a biomechanical signature of cytotoxicityMiguel de Jesus, Alexander H Settle, Daan Vorselen, et al.Journal of Inflammation Research|December 14, 2022
DNA Repair Mechanisms are Activated in Circulating Lymphocytes of Hospitalized Covid-19 PatientsMaria Belland Olsen, Camilla Huse, Mirta Mittelstedt Leal de Sousa, et al.Pageof 128